Post-marketing phase IV trial of Ad5FGF-4 (Generx)

Trial Profile

Post-marketing phase IV trial of Ad5FGF-4 (Generx)

Phase of Trial: Phase IV

Latest Information Update: 08 Apr 2015

At a glance

  • Drugs Alferminogene-tadenovec (Primary)
  • Indications Angina pectoris
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 08 Apr 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top